192 related articles for article (PubMed ID: 31616059)
21. Activation of
Biran A; Yin S; Kretzmer H; Ten Hacken E; Parvin S; Lucas F; Uduman M; Gutierrez C; Dangle N; Billington L; Regis FF; Rassenti LZ; Mohammad A; Hoffmann GB; Stevenson K; Zheng M; Witten E; Fernandes SM; Tausch E; Sun C; Stilgenbauer S; Brown JR; Kipps TJ; Aster JC; Gnirke A; Neuberg DS; Letai A; Wang L; Carrasco RD; Meissner A; Wu CJ
Cancer Res; 2021 Dec; 81(24):6117-6130. PubMed ID: 34686499
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of δ-like ligand 4 and Notch1 in acute myeloid leukemia.
Zhang J; Ma D; Ye J; Zang S; Lu F; Yang M; Qu X; Sun X; Ji C
Oncol Rep; 2012 Oct; 28(4):1503-11. PubMed ID: 22858860
[TBL] [Abstract][Full Text] [Related]
23. The bispecific antibody HB-32, blockade of both VEGF and DLL4 shows potent anti-angiogenic activity in vitro and anti-tumor activity in breast cancer xenograft models.
Zhou R; Wang S; Wen H; Wang M; Wu M
Exp Cell Res; 2019 Jul; 380(2):141-148. PubMed ID: 31034805
[TBL] [Abstract][Full Text] [Related]
24. Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia.
Xiong H; Mancini M; Gobert M; Shen S; Furtado GC; Lira SA; Parkhurst CN; Garambois V; Brengues M; Tadokoro CE; Trimarchi T; Gómez-López G; Singh A; Khiabanian H; Minuzzo S; Indraccolo S; Lobry C; Aifantis I; Herranz D; Lafaille JJ; Maraver A
Theranostics; 2021; 11(4):1594-1608. PubMed ID: 33408769
[TBL] [Abstract][Full Text] [Related]
25. Substrate stiffness modulates endothelial cell function via the YAP-Dll4-Notch1 pathway.
Matsuo E; Okamoto T; Ito A; Kawamoto E; Asanuma K; Wada K; Shimaoka M; Takao M; Shimamoto A
Exp Cell Res; 2021 Nov; 408(1):112835. PubMed ID: 34543658
[TBL] [Abstract][Full Text] [Related]
26. Common nonmutational
Fabbri G; Holmes AB; Viganotti M; Scuoppo C; Belver L; Herranz D; Yan XJ; Kieso Y; Rossi D; Gaidano G; Chiorazzi N; Ferrando AA; Dalla-Favera R
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2911-E2919. PubMed ID: 28314854
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-384-5p Promotes Endothelial Progenitor Cell Proliferation and Angiogenesis in Cerebral Ischemic Stroke through the Delta-Likeligand 4-Mediated Notch Signaling Pathway.
Fan J; Xu W; Nan S; Chang M; Zhang Y
Cerebrovasc Dis; 2020; 49(1):39-54. PubMed ID: 31927543
[TBL] [Abstract][Full Text] [Related]
28. Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia.
Arruga F; Gizdic B; Serra S; Vaisitti T; Ciardullo C; Coscia M; Laurenti L; D'Arena G; Jaksic O; Inghirami G; Rossi D; Gaidano G; Deaglio S
Leukemia; 2014 May; 28(5):1060-70. PubMed ID: 24170027
[TBL] [Abstract][Full Text] [Related]
29. Targeted Notch1 inhibition with a Notch1 antibody, OMP-A2G1, decreases tumor growth in two murine models of prostate cancer in association with differing patterns of DNA damage response gene expression.
Ahmed AA; Robinson T; Palande M; Escara-Wilke J; Dai J; Keller ET
J Cell Biochem; 2019 Oct; 120(10):16946-16955. PubMed ID: 31099068
[TBL] [Abstract][Full Text] [Related]
30. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
[TBL] [Abstract][Full Text] [Related]
31. Kruppel-like factor 4 regulates developmental angiogenesis through disruption of the RBP-J-NICD-MAML complex in intron 3 of Dll4.
Boriushkin E; Zhang H; Becker M; Peachey J; Shatat MA; Adams RH; Hamik A
Angiogenesis; 2019 May; 22(2):295-309. PubMed ID: 30607695
[TBL] [Abstract][Full Text] [Related]
32. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
[TBL] [Abstract][Full Text] [Related]
33. NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.
Benedetti D; Tissino E; Pozzo F; Bittolo T; Caldana C; Perini C; Martorelli D; Bravin V; D'Agaro T; Rossi FM; Bomben R; Santinelli E; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Del Poeta G; Rossi D; Gaidano G; Dal Bo M; Gattei V; Zucchetto A
Leukemia; 2018 Mar; 32(3):654-662. PubMed ID: 28935990
[TBL] [Abstract][Full Text] [Related]
34. MMGZ01, an anti-DLL4 monoclonal antibody, promotes nonfunctional vessels and inhibits breast tumor growth.
Xu Z; Wang Z; Jia X; Wang L; Chen Z; Wang S; Wang M; Zhang J; Wu M
Cancer Lett; 2016 Mar; 372(1):118-27. PubMed ID: 26739060
[TBL] [Abstract][Full Text] [Related]
35. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
[TBL] [Abstract][Full Text] [Related]
36. Probing Notch1-Dll4 signaling in regulating osteogenic differentiation of human mesenchymal stem cells using single cell nanobiosensor.
Zhao Y; Yang R; Bousraou Z; Richardson K; Wang S
Sci Rep; 2022 Jun; 12(1):10315. PubMed ID: 35725756
[TBL] [Abstract][Full Text] [Related]
37.
Pozzo F; Bittolo T; Tissino E; Vit F; Vendramini E; Laurenti L; D'Arena G; Olivieri J; Pozzato G; Zaja F; Chiarenza A; Di Raimondo F; Zucchetto A; Bomben R; Rossi FM; Del Poeta G; Dal Bo M; Gattei V
Haematologica; 2021 Dec; 106(12):3125-3135. PubMed ID: 33121237
[TBL] [Abstract][Full Text] [Related]
38. Dll1 Can Function as a Ligand of Notch1 and Notch2 in the Thymic Epithelium.
Hirano KI; Hosokawa H; Yahata T; Ando K; Tanaka M; Imai J; Yazawa M; Ohtsuka M; Negishi N; Habu S; Sato T; Hozumi K
Front Immunol; 2022; 13():852427. PubMed ID: 35371023
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Molecular Mechanism of YiqiChutan Formula Regulating DLL4-Notch Signaling to Inhibit Angiogenesis in Lung Cancer.
Li J; Han R; Li J; Zhai L; Xie X; Zhang J; Chen Y; Luo J; Wang S; Sun Z; Cao Y; Lin L; Yang Q
Biomed Res Int; 2021; 2021():8875503. PubMed ID: 33628824
[TBL] [Abstract][Full Text] [Related]
40. MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo.
Jenkins DW; Ross S; Veldman-Jones M; Foltz IN; Clavette BC; Manchulenko K; Eberlein C; Kendrew J; Petteruti P; Cho S; Damschroder M; Peng L; Baker D; Smith NR; Weir HM; Blakey DC; Bedian V; Barry ST
Mol Cancer Ther; 2012 Aug; 11(8):1650-60. PubMed ID: 22679110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]